Bank of New York Mellon Corp Lowers Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Bank of New York Mellon Corp trimmed its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 5.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 253,252 shares of the company's stock after selling 13,624 shares during the period. Bank of New York Mellon Corp owned 0.51% of Astrana Health worth $7,853,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. 325 Capital LLC increased its position in Astrana Health by 30.3% during the fourth quarter. 325 Capital LLC now owns 886,916 shares of the company's stock worth $27,964,000 after purchasing an additional 206,009 shares during the last quarter. Renaissance Technologies LLC increased its position in Astrana Health by 217.6% during the fourth quarter. Renaissance Technologies LLC now owns 217,900 shares of the company's stock worth $6,870,000 after purchasing an additional 149,300 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Astrana Health by 10.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock worth $32,968,000 after purchasing an additional 101,192 shares during the last quarter. JPMorgan Chase & Co. increased its position in Astrana Health by 136.1% during the fourth quarter. JPMorgan Chase & Co. now owns 163,532 shares of the company's stock worth $5,156,000 after purchasing an additional 94,268 shares during the last quarter. Finally, First Trust Advisors LP increased its position in Astrana Health by 702.6% during the fourth quarter. First Trust Advisors LP now owns 107,343 shares of the company's stock worth $3,385,000 after purchasing an additional 93,969 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 3.4%

ASTH stock traded up $0.77 during mid-day trading on Friday, hitting $23.27. 296,000 shares of the company were exchanged, compared to its average volume of 277,934. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $1.30 billion, a P/E ratio of 32.32, a PEG ratio of 0.85 and a beta of 0.84. The business has a fifty day simple moving average of $24.82 and a 200-day simple moving average of $29.84. Astrana Health, Inc. has a 12-month low of $22.45 and a 12-month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The company had revenue of $620.39 million for the quarter, compared to analysts' expectations of $628.11 million. During the same period last year, the business earned $0.31 EPS. The company's quarterly revenue was up 53.4% compared to the same quarter last year. On average, equities research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Barclays assumed coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective for the company. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Astrana Health presently has an average rating of "Moderate Buy" and a consensus price target of $53.29.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.